Glial reactions in Parkinson's disease

McGeer, Patrick L., McGeer, Edith G.·2008·Movement Disorders

Cited by (700)

Items 501–600 of 700

  1. Interferon Gamma Potentiates the Injury Caused by MPP(+) on SH-SY5Y Cells, Which is Attenuated by the Nitric Oxide Synthases Inhibition
    Simoneide Souza Titze-de-Almeida, Cátia Lustosa, Camila Hillesheim Horst, Elaine Aparecida Del Bel, Ricardo Titze‐de‐Almeida · 2014 · Neurochemical Research
  2. Src and Syk are targeted to an anti-inflammatory ethanol extract of Aralia continentalis
    Hye Yoon Jeong, Sang Hyun Moh, Yanyan Yang, Tao Yu, Ju-Eun Oh, Deok Jeong, Deok Hyo Yoon, Ki Myun Park, Sukchan Lee, Tae Woong Kim et al. · 2012 · Journal of Ethnopharmacology
  3. Cytomorphological and Cytochemical Identification of Microglia
    Subhajit Das Sarma, Koushik Chatterjee, Himadri Dinda, Dhriti Chatterjee, Jayasri Das Sarma · 2013 · ISRN Immunology
  4. MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia
    Kathryn E. Sánchez, Kathleen A. Maguire‐Zeiss · 2020 · Frontiers in Neuroscience
  5. Alterations of interneurons in the striatum and frontal cortex of mice during postnatal development
    Risa Eto, Manami Abe, Hiroki Kimoto, Eri Imaoka, Hiroyuki Kato, Jiro Kasahara, Tsutomu Araki · 2010 · International Journal of Developmental Neuroscience
  6. TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
    Alain Ndayisaba, K. A. Jellinger, Thomas Berger, Gregor Karl Wenning · 2019 · Journal of Neuroinflammation
  7. Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects
    Mingchao Shi, Fengna Chu, Jie Zhu · 2025 · Pharmacological Research
  8. Steady Moderate Exercise Confers Resilience Against Neurodegeneration and Neuroinflammation in a Mouse Model of Parkinson’s Disease
    Ewelina Pałasz, Anna Gąsiorowska, Patrycja Drapich, Wiktor Niewiadomski, Grażyna Niewiadomska · 2025 · International Journal of Molecular Sciences
  9. No association between NOD2 variants and Parkinson's disease
    Silke Appenzeller, Sandra Thier, Frank Papengut, Christine Klein, Johann M. Hagenah, Meike Kasten, Daniela Berg, Karin Srulijes, Thomas Gasser, Stefan Schreiber et al. · 2012 · Movement Disorders
  10. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease
    Agustín Anastasía, José Wojnacki, Gabriel A. de Erausquin, Daniel Hugo Mascó · 2011 · Neuroscience
  11. Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration
    Sandra Gómez‐López, Ana Valeria Martínez-Silva, Teresa Montiel, Daniel Osorio‐Gómez, Federico Bermúdez‐Rattoni, Lourdes Massieu, Diana Escalante‐Alcalde · 2016 · Scientific Reports
  12. Local Gastrointestinal Injury Exacerbates Inflammation and Dopaminergic Cell Death in Parkinsonian Mice
    Ana Luisa Gil-Martínez, Cristina M. Estrada, Lorena Cuenca‐Bermejo, J. A. Cano, Manuel Valiente, Carlos Manuel Martínez, Emiliano Fernández‐Villalba, María Trinidad Herrero · 2019 · Neurotoxicity Research
  13. Umbilical cord blood-derived hematopoietic stem cells improve dopaminergic neuron morphology in the MPTP-mice
    Hiranmoy Das · 2013 · Frontiers in bioscience
  14. Effects of mangiferin and its combination with nNOS inhibitor 7‐nitro‐indazole (7‐NI) in 6‐hydroxydopamine (6‐OHDA) lesioned Parkinson's disease rats
    Prafulla Chandra Tiwari, Manju Jyoti Chaudhary, Rishi Pal, Rajendra Nath · 2022 · Fundamental and Clinical Pharmacology
  15. Emerging insights into Lipocalin-2: Unraveling its role in Parkinson's Disease
    Ruqing Qiu, Yunjia Cai, Yana Su, Kangli Fan, Zhihui Sun, Ying Zhang · 2024 · Biomedicine & Pharmacotherapy
  16. Interleukin 18 and the brain: neuronal functions, neuronal survival and psycho-neuro-immunology during stress
    Silvia Alboni, Fabio Tascedda, Akihito Uezato, Shuei Sugama, Zuxin Chen, Maria Cecília Garibaldi Marcondes, Bruno Conti · 2025 · Molecular Psychiatry
  17. Sensory-motor performance after acute glutathione depletion by l-buthionine sulfoximine injection into substantia nigra pars compacta
    Mei-Li Díaz-Hung, Lisette Blanco, Nancy Pavón Fuentes, Rilda León-Martínez, Bárbara Estupiñán, Eduardo Orta, Klaudia Martínez, Isabel Fernández · 2014 · Behavioural Brain Research
  18. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B
    Christine A. Vaine, David S. Shin, Christina H. Liu, William T. J. Hendriks, Jyotsna Dhakal, Kyle Shin, Nutan Sharma, D. Cristopher Bragg · 2016 · Neurobiology of Disease
  19. Neuromelanin inhibits CXCL10 expression in human astroglial cells
    Neda Saffarian Tousi, Daniel J. Buck, Luigi Zecca, Randall L. Davis · 2010 · Neuroscience Letters
  20. Contribution of in vitro neurotoxicology studies to the elucidation of neurodegenerative processes
    Marie‐Gabrielle Zurich, Florianne Monnet‐Tschudi · 2009 · Brain Research Bulletin
  21. The use of glial data in human health assessments of environmental contaminants
    Andrew David Kraft · 2015 · Toxicology
  22. Sex-Dependent Gliovascular Interface Abnormality in the Hippocampus following Postnatal Immune Activation in Mice
    Maryam Ardalan, Tetyana Chumak, Alexandra Quist, Seyedeh Marziyeh Jabbari Shiadeh, Anna-Jean Mallard, Ali H. Rafati, Carina E. Mallard · 2022 · Developmental Neuroscience
  23. Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
    Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary, Cesar V. Borlongan · 2022 · International Journal of Molecular Sciences
  24. Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice
    Venissa Machado, Ralf Gilsbach, Richa Das, Andreas Schober, Lioudmila Bogatyreva, Dieter Hauschke, Kerstin G. KRIEGLSTEIN, Klaus Unsicker, Björn Spittau · 2016 · Cell and Tissue Research
  25. Rotenone impairs brain glial energetics and locomotor behavior in bumblebees
    Jieteng Chen, Xiaohuan Mu, Huiling Liu, Qiyao Yong, Xiaoman Ouyang, Yan Liu, Li Zheng, Hao Chen, Yifan Zhai, Jie Ma et al. · 2023 · The Science of The Total Environment
  26. Nanoformulated Mutant SurR9-C84A: a Possible Key for Alzheimer’s and its Associated Inflammation
    Bhasker Sriramoju, Rupinder K. Kanwar, Jagat R. Kanwar · 2015 · Pharmaceutical Research
  27. Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease
    Xuelin Li, Shuzhi Wang, Shan Duan, Lin Long, Linsheng Zhuo, Yan Peng, Yongxia Xiong, Shuang Li, Xue Peng, Yiguo Yan et al. · 2023 · ACS Omega
  28. D-β-hydroxybutyrate inhibits microglial activation in a cell activation model in vitro
    Xu-Dong Xu, Qing Zhang, J. Tu, Zhen Ren · 2011 · 中国人民解放军军医大学学报:英文版
  29. Immune-Directed Gene Therapeutic Development for Alzheimer’s, Prion, and Parkinson’s Diseases
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2008 · Journal of Neuroimmune Pharmacology
  30. Dietary Phytochemicals in Neurodegenerative Disease
    Aurélie de Rus Jacquet, Mitali Arun Tambe, Jean‐Christophe Rochet · 2017 · Elsevier eBooks
  31. Vulnerability to Parkinson's Disease: Towards an Unifying Theory of Disease Etiology
    Bianca Marchetti, Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C. Morale · 2011 · Elsevier eBooks
  32. Is Hearing Loss a Risk Factor for Idiopathic Parkinson’s Disease? An English Longitudinal Study of Ageing Analysis
    Megan Rose Readman, Fang Wan, Ian Fairman, Sally A. Linkenauger, Trevor J. Crawford, Christopher J. Plack · 2023 · Brain Sciences
  33. Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain
    Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, Sudhanshu P. Raikwar, Raghav Govindarajan, Duraisamy Kempuraj · 2024 · International Journal of Molecular Sciences
  34. Activation and polarization of striatal microglia and astrocytes are involved in bradykinesia and allodynia in early-stage parkinsonian mice
    Xue Zhang, Zi-Lin Shen, Yawei Ji, Yin Cui, Cheng Xiao, Chunyi Zhou · 2023 · Fundamental Research
  35. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson’s disease mouse models
    Fen Zhang, Lixin Pan, Changlin Lian, Zhifeng Xu, Hongda Chen, Wenjie Lai, Xiaojue Liang, Qiyuan Liu, Haomin Wu, Yukai Wang et al. · 2024 · Brain Research Bulletin
  36. Resveratrol inhibits lipopolysaccharide-induced phagocytotic activity in BV2 cells
    Euteum Park, Do Kyung Kim, Hong Sung Chun · 2012 · Journal of the Korean Society for Applied Biological Chemistry
  37. Challenges in molecular imaging of Parkinson’s disease: A brief overview
    Michael Kassiou, Richard B. Banati, R. M. Damian Holsinger, Steven R. Meikle · 2008 · Brain Research Bulletin
  38. Striatal Glutamate Degenerates Thalamic Neurons
    Ingrid Moráles, Catalina Yanos, Clara Rodriguez‐Sabate, Alberto Sánchez, Manuel Rodríguez · 2013 · Journal of Neuropathology & Experimental Neurology
  39. Involvement of inhibitory PAS domain protein in neuronal cell death in Parkinson’s disease
    Satoru Torii, Shuya Kasai, Ayumi Suzuki, Y Todoroki, K Yokozawa, K-I Yasumoto, Naohiko Seike, Hiroshi Kiyonari, Yoshiko Mukumoto, Akiyoshi Kakita et al. · 2015 · Cell Death Discovery
  40. Alpha‐Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies
    Mahnoor Mahnoor, Sarwat Jahan, Laila Elahi, Muhammad Zakria, Rabia Rabia, Muhammad Aimen Ikram, Najeeb Ullah · 2025 · Clinical and Experimental Pharmacology and Physiology
  41. The Effects of Deep Brain Stimulation on Balance in Parkinson’s Disease as Measured Using Posturography—A Narrative Review
    Bradley Lonergan, Barry M. Seemungal, Matteo Ciocca, Yen Tai · 2025 · Brain Sciences
  42. Targeted Toxicants to Dopaminergic Neuronal Cell Death
    Huajun Jin, Arthi Kanthasamy, Dilshan S. Harischandra, Vellareddy Anantharam, Ajay Rana, Anumantha Kanthasamy · 2014 · Methods in molecular biology
  43. By Changing Dimensionality, Sequential Culturing of Midbrain Cells, rather than Two-Dimensional Culture, Generates a Neuron-Glia Ratio Closer to in vivo Adult Midbrain
    K. Ganapathy, S. Sowmithra, R. Bhonde, I. Datta · 2016 · Cells Tissues Organs
  44. Purines in Parkinson’s: Adenosine A2A Receptors and Urate as Targets for Neuroprotection
    Rachit Bakshi, Robert Logan, Michael A. Schwarzschild · 2015 · Current topics in neurotoxicity
  45. Inflammation and Parkinson’s Disease
    Miquel Vila · 2010 · Elsevier eBooks
  46. Immune signaling and function in neurodegeneration
    Yvonne L. Latour, Dorian B. McGavern · 2026 · Journal of Clinical Investigation
  47. Neuroinflammation During Parkinson’s Disease: Key Cells and Molecules Involved in It
    Priyobrata Sinha, Nabanita Ghosh, Soham Mitra, Arindam Bhattacharyya · 2016 · Springer eBooks
  48. Design and Implementation of a Dual-Probe Microsampling Apparatus for the Direct Analysis of Adherent Mammalian Cells by Ion Mobility-Mass Spectrometry
    Taylor M. Domenick, Vinata Vedam‐Mai, Richard A. Yost · 2020 · Analytical Chemistry
  49. Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities
    Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi · 2021 · Molecular Neurobiology
  50. Lesion-associated microglia and macrophages mediate corralling and react with massive phagocytosis for debris clearance and wound healing after LPS-induced dopaminergic depletion
    P. Heman-Bozadas, C. Romero, P. Martínez-Remedios, Irina Freitag-Berenguel, A. Frías, Elena Saavedra-López, Paola V. Casanova, Meritxell Roig-Martínez, George P. Cribaro, María de Jesús Rovirosa-Hernández et al. · 2022 · Journal of Neuroimmunology
  51. Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado–Joseph Disease
    Ana Bela Campos, Sara Duarte‐Silva, Bruno Fernandes, Bárbara Coimbra, Jonas Campos, Daniela Monteiro‐Fernandes, Andreia Teixeira‐Castro, António Francisco Ambrósio, Patrı́cia Maciel · 2022 · Cells
  52. Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy
    Winston T. Chu, Jesse Hall, Anjela Gurrala, Alexander Becsey, Shreya Raman, Michael S. Okun, Catherine Flores, Benoit I. Giasson, David E. Vaillancourt, Vinata Vedam‐Mai · 2022 · ACS Chemical Neuroscience
  53. Glimepiride Prevents 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Dopamine Neurons Degeneration Through Attenuation of Glia Activation and Oxidative Stress in Mice
    Mariam D. Oduola-Akande, I. Ishola, T. Olubodun-Obadun, Adeola J. Akande, O. Adeyemi · 2023 · Neurotoxicity research
  54. Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
    Firzan Nainu, Sukamto Salang Mamada, Harapan Harapan, Talha Bin Emran · 2023 · Advances in experimental medicine and biology
  55. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice
    Cho-Chen Hsieh, Muh-Shi Lin, Kuo‐Feng Hua, Wei‐Jung Chen, Chai-Ching Lin · 2017 · Neuroscience Letters
  56. Introduction to Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
    Dennis W. Dickson · 2011 · Wiley eBooks
  57. Anti-inflammatory role of GM1 and modulatory effects of gangliosides on microglia functions
    Danny Galleguillos, Qian Wang, Noam Steinberg, Gaurav Shrivastava, Kamaldeep Dhami, Karin Rubinstein, Fabrizio Giuliani, Matthew A. Churchward, Christopher Power, Kathryn G. Todd et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  58. A Water-soluble Form of Dihydroquercetin Reduces LPS-induced Astrogliosis, Vascular Remodeling, and mRNA VEGF-A Levels in the Substantia Nigra of Aged Rats
    Alalykina Elena S, Tatyana Sergeyeva, Ananyan Michail A, Черенков Иван Анатольевич, Sergeev Valeriy G · 2024 · Journal of Neuroscience and Neurological Disorders
  59. Enhanced IRE1α Phosphorylation/Oligomerization-Triggered XBP1 Splicing Contributes to Parkin-Mediated Prevention of SH-SY5Y Cell Death under Nitrosative Stress
    Tsung‐Lang Chiu, Hsin‐Yi Huang, Hui‐Fen Chang, Hsin-Rong Wu, Mei-Jen Wang · 2023 · International Journal of Molecular Sciences
  60. Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis
    Han Wang, Yi-Ti Liu, Yanling Ren, Xiaoyan Guo, Yi Wang · 2024 · Journal of Neuroimmunology
  61. Neuroprotection of Dopaminergic Neurons by Hominis Placenta Herbal Acupuncture in in vitro and in vivo Models of Parkinson’s Disease Induced by MPP+/MPTP Toxicity
    Hyung Joon Jun, Sang‐Soo Nam, Young Suk Kim · 2015 · 대한침구학회지
  62. Effect of Immature Citrus sunki Peel Extract on Neuronal Cell Death
    Woon Chul Ko, Sun Ryung Lee · 2015 · Korean Journal of Medicinal Crop Science
  63. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease
    Rafael Gonzalo‐Gobernado, Diana Reimers, Marı́a José Casarejos, Lucía Calatrava-Ferreras, Manuela Vallejo-Muñoz, Adriano Jiménez‐Escrig, Juan José Díaz-Gil, Gonzalo M. Ulzurrun de Asanza, Eulalia Bazán · 2020 · Brain Sciences
  64. Apoptosis-associated speck-like protein containing a CARD-mediated release of matrix metalloproteinase 10 stimulates a change in microglia phenotype
    Kathryn E. Sánchez, Kiran Bhaskar, Gary A. Rosenberg · 2022 · Frontiers in Molecular Neuroscience
  65. Common Pathways to Neurodegeneration and Co-morbid Depression
    Darcy Litteljohn, Emily N. Mangano, Shawn P. Hayley · 2010 · Springer eBooks
  66. Neuroglia in Neurological Diseases
    Alexei Verkhratsky, Arthur Morgan Butt · 2013 · Wiley eBooks
  67. Calpain Mediated Neurodegeneration in Parkinson’s disease
    Varduhi H. Knaryan · 2023 · Neurochemical Journal
  68. Marine Bioactive Components and Chronic Neuroinflammation: Focus on Neurodegenerative Disease
    Elda Favari, Cinzia Parolini · 2025 · Marine Drugs
  69. Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data
    Sabrina Strobel, Jeswinder Sian‐Hülsmann, Dennis Tappe, K. A. Jellinger, Peter Franz Riederer, Camelia‐Maria Monoranu · 2024 · Cells
  70. Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study
    Filipa Monteiro Rocha, Avishek Roy, Mukesh Varshney, Amit Kumar · 2025 · Alzheimer s & Dementia
  71. High Levels of Anti-Ganglioside Antibodies in Patients with Parkinson?s Disease Associated with Cognitive Decline
    Hatzifilippou E Arnaoutoglou M · 2015 · International Journal of Neurorehabilitation
  72. Parkinson-Erkrankung und Neuroinflammation – Zelluläre Pathologie, Mechanismen und therapeutische Optionen
    Lars Tönges, Judith Metzdorf, Samis M. A. Zella · 2018 · Fortschritte der Neurologie · Psychiatrie
  73. Glial GLP1R: A novel neuroprotector?
    Aubrey M Schonhoff, Ashley S. Harms · 2018 · Movement Disorders
  74. The Role of the Neuropeptide Substance P in the Pathogenesis of Parkinson’s Disease
    Emma Thornton, Robert Vink · 2012 · InTech eBooks
  75. Parkinson’s puzzle
    András Guseo · 2012 · Orvosi Hetilap
  76. Subventricular Zone Under the Neuroinflammatory Stress and Parkinson’s Disease
    Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Hiroshi Nagasaki, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota · 2011 · Cellular and Molecular Neurobiology
  77. Lipid-like components released from degenerating dopaminergic neurons trigger the dynamic migration of microglia
    Hyemin Kim, June‐Hee Park, Kyungjin Kim · 2012 · Biochemical and Biophysical Research Communications
  78. Effects of Longanae Arillus Water Extract on Inflammatory Response and Cytokines in Mouse Macrophage Cells
    Mirim Kim, Eun‐Mee Lim · 2014 · The Journal of Korean Obstetrics and Gynecology
  79. Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases
    A. Raquel Esteves, Diana Filipa Silva, Daniel Santos, Emanuel Candeias, Filipa Filipe, Sandra M. Cardoso · 2018 · InTech eBooks
  80. Parkinson’s Disease: An Overview of Etiology, Clinical Manifestations, and Treatment
    Arif Dalvi, Kelly E. Lyons, Rajesh Pahwa · 2014 · Springer eBooks
  81. Microglia Monitor and Protect Neuronal Function Via Specialized Somatic Purinergic Junctions in an Activity-Dependent Manner
    Csaba Cserép, Balázs Pósfai, Barbara Orsolits, Gábor Molnár, Steffanie Heindl, Nikolett Lénárt, Rebeka Fekete, Zsófia I. László, Zsolt Lele, Anett D. Schwarcz et al. · 2019 · SSRN Electronic Journal
  82. 1980-2011: Parkinson's Disease and Advance in Stem Cell Research
    Lidia Cova, Marie‐Thérèse Armentero · 2011 · InTech eBooks
  83. Neuro-protective effects of Ligustri Fructus by suppression of oxidative stress in mouse model of Parkinson’s disease
    Minsook Ye, Min Hwan Kim, Hyunsu Bae · 2016 · Oriental Pharmacy and Experimental Medicine
  84. Exploring the Causal Association Between 91 Circulating Inflammatory Proteins and Neurodegenerative Diseases: A Bidirectional Two‐Sample Mendelian Randomization and Bioinformatics Analysis
    Ziwei Gong, Rong Cao, Hong Zhu · 2025 · Brain and Behavior
  85. Adenosine Receptors and Neuroinflammation
    Antonella Ferrante, Roberta De Simone, Maria Antonietta Ajmone‐Cat, Luisa Minghetti, Patrizia Popoli · 2018 · Springer eBooks
  86. Neuroinflammation and Parkinson’s Disease
    Francisco Ros‐Bernal, J. E. Yuste, Ernesto Tarragón, V. Ortiz, A. Gómez, C. M. Ros, Emiliano Fernández‐Villalba, María Trinidad Herrero · 2014 · Springer eBooks
  87. Quantitative Evaluation of Changes in the Striatal Astrocyte Axons in Simulated Parkinsonism
    Д. Н. Воронков, Р. М. Худоерков, Ю.В. Дикалова, Larisa Sheloukhova · 2016 · Bulletin of Experimental Biology and Medicine
  88. Treatment of Parkinson’s disease using human stem cells
    Charlotte Palmer, Raquel Coronel, Isabel Liste · 2016 · Journal of Stem Cell Research and Medicine
  89. Disruption of intracellular signaling
    Anumantha G. Kanthasamy, Jie Denny Luo, Dharmin Rokad, Adhithiya Charli · 2020 · Elsevier eBooks
  90. Phenolic composition and neuroprotective effects of the ethyl-acetate fraction from Inonotus sanghuang against H2O2-induced apoptotic cell death of primary cortical neuronal cells
    Kun Liu, Cuilian Qi, Yihang Liu, Yaping Huai, Huagang Hu, Xuan Xiao, Junpeng Wang · 2022 · Food Science and Biotechnology
  91. In vitro cell models in predicting blood-brain barrier permeability of drugs
    Jenni J. Hakkarainen · 2013 · UEF eRepo (University of Eastern Finland)
  92. Exploring Pulmonary Dysfunction in Parkinson’s Disease: The Role of Impulse Oscillometry—A Systematic Review
    Alexandra-Cristiana Gache, Elena Danteș, Elena Mocanu, Andreea-Cristina Postu, Cristian Opariuc‐Dan, Any Docu Axelerad · 2025 · Journal of Clinical Medicine
  93. The Interplay Between CB2 and NMDA Receptors in Parkinson’s Disease
    Irene Reyes‐Resina, Jaume Lillo, Iu Raïch, Joan Biel Rebassa, Toni Capó, Gemma Navarro, Gemma Navarro · 2025 · International Journal of Molecular Sciences
  94. Immunity in Parkinson's disease – The role of innate responses
    Aditi S Iyengar, Peter Robert Dunkley, Phillip W. Dickson · 2025 · Journal of Neuroimmunology
  95. Modified Mediterranean diet effects on Parkinson’s disease (MED-PARK): a single-centre randomised controlled trial protocol
    Elenamaria Pirovano, Franca Marino, Elena Giulia Rossi, Andrea Gennari, Emanuela Rasini, Margherita Uslenghi, Inês Figueira, Licia Iacoviello, Marco Ferrari, Marco Cosentino · 2025 · BMJ Open
  96. Alpha-Synuclein and the Immune Response in Parkinson’s Disease
    Cintia Roodveldt, Adahir Labrador‐Garrido, Guillermo Izquierdo, David Pozo · 2011 · InTech eBooks
  97. Changes in Neuroglial Interactions in Nigrostriatal Brain Structures on Modeling of Dopamine System Dysfunction
    Д. Н. Воронков, Р. М. Худоерков, Доведова Елизавета Леонтьевна · 2014 · Neuroscience and Behavioral Physiology
  98. Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases
    Fatemeh Shojaei, Naemeh Tavakolinia, Adeleh Divsalar, Thomas Haertlé, Ali Akbar Saboury, Mohsen Nemat‐Gorgani, Maria P. Abbracchio · 2014 · Journal of the Iranian Chemical Society
  99. Innate and Adaptive Immune-Mediated Neuroinflammation and Neurodegeneration in Parkinson’s Disease
    Rebecca A. Wilshusen, Rodney Lee Mosley · 2014 · Springer eBooks
  100. Study of Microglial and Astroglial Alterations Induced by Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment in Mouse Brain
    Nabanita Ghosh, Soham Mitra, Priyobrata Sinha, Nilkanta Chakrabarti, Arindam Bhattacharyya · 2019 · Proceedings of the Zoological Society